Sheelagh Frame
- Molecular Biology top 1%
- Wnt/β-catenin signaling in development and cancer 9
- Cancer-related gene regulation 9
- Protein Degradation and Inhibitors 3
- Cell Biology top 1%
- Microtubule and mitosis dynamics 3
- Oncology top 5%
- Cancer-related Molecular Pathways 15
- Cancer Research top 5%
-
- Advanced Breast Cancer Therapies 14
-
- Chronic Lymphocytic Leukemia Research 6
-
- Acute Myeloid Leukemia Research 4
- Co-authors
- Philip CohenRicardo M. BiondiAdam R. ColeSimon R. GreenAthos Gianella-BorradoriAllan BalmainNick MorriceDaniella Zheleva
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Sheelagh Frame
33 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Molecular Biology 4.0k
- Cell Biology 839
- Cellular and Molecular Neuroscience 595
- Oncology 885
- Cancer Research 364
Countries citing papers authored by Sheelagh Frame
This map shows the geographic impact of Sheelagh Frame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheelagh Frame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheelagh Frame more than expected).
Fields of papers citing papers by Sheelagh Frame
This network shows the impact of papers produced by Sheelagh Frame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheelagh Frame. The network helps show where Sheelagh Frame may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheelagh Frame, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 13 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 38 | |
| 4 | 2020 | 64 | |
| 5 | 2017 | 0 | |
| 6 | 2015 | 6 | |
| 7 | 2010 | 1 | |
| 8 | Abstract #3863: Derivatives of seliciclib with improved potency both in vitro and in vivo as novel cyclin dependent kinase (CDK) inhibitors | 2009 | 1 |
| 9 | 2008 | 25 | |
| 10 | 2006 | 16 | |
| 11 | 2006 | 47 | |
| 12 | CYC202 (R-Roscovitine) induces apoptosis in multiple myeloma cells by down regulation of Mcl-1 | 2004 | 4 |
| 13 | 2002 | 176 | |
| 14 | A Common Phosphate Binding Site Explains the Unique Substrate Specificity of GSK3 and Its Inactivation by Phosphorylationbreakdown → | 2001 | 583 |
| 15 | GSK3 takes centre stage more than 20 years after its discoverybreakdown → | 2001 | 1153 |
| 16 | 2001 | 80 | |
| 17 | The renaissance of GSK3breakdown → | 2001 | 1285 |
| 18 | 2000 | 80 | |
| 19 | 1999 | 196 | |
| 20 | 1998 | 29 |
About Sheelagh Frame
Sheelagh Frame is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (15 papers), Advanced Breast Cancer Therapies (14 papers), Wnt/β-catenin signaling in development and cancer (9 papers), Cancer-related gene regulation (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Myeloid Leukemia Research (4 papers), Microtubule and mitosis dynamics (3 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Molecular Biology (4.0k citations), Cell Biology (839 citations) and Cellular and Molecular Neuroscience (595 citations). Sheelagh Frame has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Philip Cohen, Ricardo M. Biondi, Adam R. Cole, Simon R. Green, Athos Gianella-Borradori, Allan Balmain, Nick Morrice, Daniella Zheleva, Guillermo Velasco and Christopher Armstrong. Their work appears in journals such as Cancer Research, FEBS Letters, Biochemical Journal, Cell Death Discovery and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.